[Role of the sympathetic nervous system in the protective effect of the selective kappa-opiate agonist dynorphin A(1-13) on frequency of cardiac arrhythmias during myocardial ischemia].
Mikhaĭlova
S D
SD
Vasil'eva
T V
TV
Semushkina
T M
TM
Storozhakov
G I
GI
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D002415:Cats; D004399:Dynorphins / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects / Q000294:innervation; D017202:Myocardial Ischemia / Q000150:complications* / Q000503:physiopathology; D010446:Peptide Fragments / Q000494:pharmacology*; D017473:Receptors, Opioid, kappa / Q000819:agonists*; D013564:Sympathetic Nervous System
D000889:Anti-Arrhythmia Agents; D010446:Peptide Fragments; D017473:Receptors, Opioid, kappa; C026843:dynorphin (1-13); D004399:Dynorphins